Nadolol (1 x 80 mg) Tablets (Invamed, Inc)

DRUG2 trials

Sponsors

Sandoz, University of Arizona

Conditions

CAR T-Cell TherapyCell TherapyChest PainDonor Lymphocyte InfusionHematopoetic Stem Cell TransplantationHigh Blood PressureLeukemiaLymphoma

Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

RecruitingNCT06643221

University of ArizonaCAR T-Cell Therapy, Cell Therapy, Donor Lymphocyte Infusion +3

Start: 2018-01-24End: 2028-12-30Target: 100Updated: 2024-10-16

Phase 1

Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions

CompletedNCT00960245

SandozChest Pain, High Blood Pressure, Migraine Headaches

Start: 1994-07-31End: 1994-07-31Updated: 2017-03-28

Related Papers

Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16+ NK cell–mediated cytotoxicity

Journal of Translational Medicine2026-03-03

Exercise-Mobilized Lymphocytes Enhance the Function of Cytokine-Induced Memory-like NK-cells Against Myeloid Leukemia.

2026-01-15